Workshop 1 – Technology & Entrepreneurship
Date: 24 July (Friday) 10:40 – 12:10 (GMT+8)
Venue: www.bioasiataiwan.com - Online event platform
Dr. Traverso is an Assistant Professor in the Department of Mechanical Engineering at the Massachusetts Institute of Technology and in the Division of Gastroenterology, Brigham and Women’s Hospital (BWH), Harvard Medical School. Dr. Traverso grew up in Peru, Canada and the United Kingdom. He received his BA from Trinity College, University of Cambridge, UK, and his PhD from the lab of Prof. Bert Vogelstein at Johns Hopkins University. He subsequently completed medical school at the University of Cambridge, internal medicine residency at the Brigham and Women’s Hospital and his gastroenterology fellowship training at Massachusetts General Hospital, both at Harvard Medical School. Dr. Traverso’s previous work focused on the development of novel molecular tests for the early detection of colon cancer. For his post-doctoral research, he transitioned to the fields of chemical and biomedical engineering in the laboratory of Professor Robert Langer at the Massachusetts Institute of Technology (MIT) where he developed a series of novel technologies for drug delivery as well as physiological sensing via the gastrointestinal tract.
Dr. Traverso’s work has been published in the New England Journal of Medicine, The Lancet, the Journal of the American Medical Association, Nature, Science, Nature Biotechnology, Nature Materials, Nature Communications, Science Translational Medicine and Cancer Research. He has been the recipient of the Grand Prize of the Collegiate Inventors Competition, a Research Fellowship from Trinity College, and was named one of the most promising innovators under 35 by the MIT Tech Review’s TR 35.
His current research program is focused on developing the next generation of drug delivery systems to enable efficient delivery of therapeutics through the gastrointestinal tract as well developing novel ingestible electronic devices for sensing a broad array of physiologic and pathophysiologic parameters. Additionally, Dr. Traverso continues his efforts towards the development of novel diagnostic tests that enable the early detection of cancer.
Dr. Traverso is a co-founder of Lyndra Therapeutics, Vivtex, Suono Bio and Celero Systems.
Speech title & Synopsis
Medication non-adherence (non-compliance) represents a major barrier to effective clinical care. In developed nations, only 50% of patients take their medications as prescribed, manifesting in more than $100 billion in avoidable hospitalizations every year in the United states alone and the numbers are far worse in the developing world. In his seminar, Dr. Traverso will present a novel platform and will touch on the fundamental aspects which are are core to the founding of a biotechnology company.